Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 163,796 | 146,808 | 135,405 | 123,601 | 117,715 |
| Cost of Goods | 2,524 | 2,535 | 1,876 | 1,645 | 1,574 |
| Gross Profit | 161,272 | 144,273 | 133,529 | 121,956 | 116,141 |
| Operating Expenses | 126,204 | 115,308 | 102,736 | 91,424 | 87,132 |
| Operating Income | 35,592 | 29,500 | 31,669 | 31,177 | 29,583 |
| Other Income | 6,004 | 5,493 | 5,139 | 5,208 | 3,347 |
| Pre-tax Income | 41,596 | 34,993 | 36,808 | 36,385 | 32,930 |
| Income Tax | 6,108 | 7,231 | 5,453 | 5,007 | 5,402 |
| Net Income Continuous | 35,488 | 27,762 | 31,355 | 31,378 | 27,528 |
| Net Income | $35,488 | $27,762 | $31,355 | $31,378 | $27,528 |
| EPS Basic Total Ops | 0.34 | 0.27 | 0.29 | 0.31 | 0.27 |
| EPS Basic Continuous Ops | 0.34 | 0.27 | 0.30 | 0.31 | 0.27 |
| EPS Diluted Total Ops | 0.32 | 0.25 | 0.27 | 0.28 | 0.25 |
| EPS Diluted Continuous Ops | 0.32 | 0.25 | 0.28 | 0.28 | 0.25 |
| EPS Diluted Before Non-Recurring Items | 0.32 | 0.25 | 0.28 | N/A | N/A |
| EBITDA(a) | $35,790 | $29,679 | $22,813 | $31,466 | $32,028 |